Sleep-promoting action of the endogenous melatonin in schizophrenia compared to healthy controls

International Journal of Psychiatry in Clinical Practice

Volumn 15, Issue 4, 2011, Pages 311-315

  Afonso, Pedro ^a   Figueira, Maria Lusa ^b   Paiva, Teresa ^b  

^a Psychiatric Hospital Center of Lisbon   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Actigraphy; Melatonin; Pittsburgh Sleep Quality Index; Schizophrenia; Sleep

Indexed keywords

CHLORPROMAZINE; MELATONIN;

ACTIMETRY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEBEPHRENIA; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; LIGHT; MALE; MENTAL DISEASE; OUTPATIENT; PARANOID SCHIZOPHRENIA; PATHOGENESIS; PITTSBURGH SLEEP QUALITY INDEX; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RESIDUAL SCHIZOPHRENIA; SALIVA ANALYSIS; SCHIZOPHRENIA; SCORING SYSTEM; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; UNDIFFERENTIATED SCHIZOPHRENIA; WRIST;

ACTIGRAPHY; ADULT; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; SALIVA; SCHIZOPHRENIA; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 80053985387     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2011.605954     Document Type: Article

References (23)

1. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 1997;12:657-65. (Pubitemid 127477103)
2. Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert, SM. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91-102. (Pubitemid 27332996)
3. Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994;17:638-45. (Pubitemid 24348457)
4. Fanget F, Claustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry 1989;25:499-501. (Pubitemid 19063799)
5. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59: 22-33. (Pubitemid 29001829)
6. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989;4:95-104.
7. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-7. (Pubitemid 36750143)
8. Chae KY, Kripke DF, Poceta JS, Shadan F, Jamil SM, Cronin JW, Kline LE. Evaluation of immobility time for sleep latency in actigraphy. Sleep Med 2009;10:621-5.
9. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28: 193-213. (Pubitemid 19144991)
10. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): Rationale and standardization. Br J Psychiatry 1989;155:59-65. (Pubitemid 19270851)
11. Hughes RJ, Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 1997;20:124-31. (Pubitemid 27195046)
12. Madjirova NP, Petrova NS, Delchev NK. Daily rhythmicity of temperature, pulse and blood pressure in schizophrenic patients. Schizophr Res 1995;14:183.
13. Brunner P, Söz er-Topcular N, Jockers R, Ravid R, Angeloni D, Fraschini F, et al. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur J Histochem 2006;50:311-16. (Pubitemid 351480093)
14. Afonso P, Brissos S, Figueira ML, Paiva T. Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep. Schizophr Res 2010;120:227-8.
15. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Br äu nig P, Marler M. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151-63. (Pubitemid 24078480)
16. Vigan ò D, Lissoni P, Rovelli F, Roselli MG, Malugani F, Gavazzeni C, et al. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Neuro Endocrinol Lett 2000;22:137-41. (Pubitemid 32396392)
17. C laustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005;9:11-24. (Pubitemid 40092915)
18. Cowen P, Plasma melatonin during desmethylimipramine treatment: Evidence for changes in noradrenergic transmission. Br J Clin Pharmacol 1985;19:799-805. (Pubitemid 15232149)
19. Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997;36:159-63. (Pubitemid 27472513)
20. Pacchierotti C, Lapichino S, Bossini L, Pieraccini F, Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001;22:18-32. (Pubitemid 32099716)
21. Mann K, Rossbach W, Müller MJ, Müller-Siecheneder F, Pott T, Linde I, et al. Nocturnal hormone profi les in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology 2006;3:256-64. (Pubitemid 41740445)
22. Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:237-41. (Pubitemid 46362644)
23. Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N, Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000;61:373-7. (Pubitemid 30345940)